Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses

Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses

US Patent 11402381 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antenna apparatus, method for producing antenna apparatus, radar, and terminal2025
Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stro2025
IGFBP7 ratio for HFpEF2025
Computerized method and laboratory equipment for fast detection of failure in la2025
Binding agent and assay for PIVKA2025
Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protei2024
Sensors based on negative capacitance field effect transistors2023
Nanostructure featuring nano-topography with optimized electrical and biochemica2023
Binding agent and assay for PIVKA2022
Screening method for a target nerve to ablate for the treatment of inflammatory 2022
Ultrasensitive sensor based on a piezoelectric transistor2022
Ultrasensitive sensor based on a piezoelectric transistor2021